Description: Introducing WockAIR® - A dry powder inhaler for the treatment of Asthma and COPD
(budesonide/formoterol fumarate dihydrate, inhalation powder)
(Based on 80-125% bioequivalence limits for AUC, Cmax, and standard flow parameters)
WockAIR ® is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate:¹